NO20022334L - Ny sammensetning og anvendelse - Google Patents

Ny sammensetning og anvendelse

Info

Publication number: NO20022334L
Authority: NO; Norway
Prior art keywords: application; new composition; composition; new
Prior art date: 1999-11-16

Application number

NO20022334A

Other languages

English (en)

Other versions

NO20022334D0 (no

NO329926B1 (no

Inventor

Nicola Jayne Lilliott

Donald Colin Mackenzie

Karen Lewis

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-16

Filing date

2002-05-15

Publication date

2002-07-09

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27447849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20022334(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-11-16 Priority claimed from GBGB9927119.9A external-priority patent/GB9927119D0/en

1999-11-16 Priority claimed from GBGB9927120.7A external-priority patent/GB9927120D0/en

2000-05-31 Priority claimed from GB0013236A external-priority patent/GB0013236D0/en

2000-05-31 Priority claimed from GB0013240A external-priority patent/GB0013240D0/en

2002-05-15 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2002-05-15 Publication of NO20022334D0 publication Critical patent/NO20022334D0/no

2002-07-09 Publication of NO20022334L publication Critical patent/NO20022334L/no

2011-01-24 Publication of NO329926B1 publication Critical patent/NO329926B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

NO20022334A 1999-11-16 2002-05-15 Farmasoytisk sammensetning og fremgangsmate for fremstilling derav NO329926B1 (no)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GBGB9927119.9A GB9927119D0 (en)	1999-11-16	1999-11-16	Novel composition and use
GBGB9927120.7A GB9927120D0 (en)	1999-11-16	1999-11-16	Novel composition and use
GB0013236A GB0013236D0 (en)	2000-05-31	2000-05-31	Novel composition and use
GB0013240A GB0013240D0 (en)	2000-05-31	2000-05-31	Novel composition and use
PCT/GB2000/004368 WO2001035941A2 (en)	1999-11-16	2000-11-16	Novel composition based on a thiazolidinedione and metformin and use

Publications (3)

Publication Number	Publication Date
NO20022334D0 NO20022334D0 (no)	2002-05-15
NO20022334L true NO20022334L (no)	2002-07-09
NO329926B1 NO329926B1 (no)	2011-01-24

Family

ID=27447849

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20022334A NO329926B1 (no)	1999-11-16	2002-05-15	Farmasoytisk sammensetning og fremgangsmate for fremstilling derav

Country Status (40)

Country	Link
US (1)	US8236345B2 (no)
EP (3)	EP1231918B1 (no)
JP (2)	JP4865975B2 (no)
KR (1)	KR100760063B1 (no)
CN (1)	CN1222290C (no)
AP (1)	AP1389A (no)
AR (2)	AR030920A1 (no)
AT (1)	ATE292466T1 (no)
AU (3)	AU775654B2 (no)
BG (1)	BG65616B1 (no)
BR (1)	BR0015605A (no)
CA (1)	CA2388846A1 (no)
CO (1)	CO5300392A1 (no)
CZ (1)	CZ302500B6 (no)
DE (1)	DE60019329T2 (no)
DK (1)	DK1231918T3 (no)
DZ (1)	DZ3251A1 (no)
EA (1)	EA004878B1 (no)
ES (1)	ES2240199T3 (no)
HK (1)	HK1049788B (no)
HR (1)	HRP20020416B1 (no)
HU (1)	HU229960B1 (no)
IL (3)	IL149618A0 (no)
MA (1)	MA25567A1 (no)
ME (1)	ME00318B (no)
MX (1)	MXPA02005005A (no)
MY (1)	MY125516A (no)
NO (1)	NO329926B1 (no)
NZ (1)	NZ518946A (no)
OA (1)	OA12513A (no)
PE (1)	PE20011011A1 (no)
PL (1)	PL200943B1 (no)
PT (1)	PT1231918E (no)
RS (1)	RS51343B (no)
SI (1)	SI1231918T1 (no)
SK (1)	SK286985B6 (no)
TW (1)	TWI240626B (no)
UA (1)	UA73150C2 (no)
UY (1)	UY26439A1 (no)
WO (1)	WO2001035941A2 (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2290130T3 (es) *	2000-05-01	2008-02-16	Aeropharm Technology, Llc	Formulacion de nucleo.
CA2453782A1 (en) *	2001-07-10	2003-01-23	Kos Life Sciences, Inc.	Core formulation comprising troglitazone and a biguanide
GB0203296D0 (en) *	2002-02-12	2002-03-27	Glaxo Group Ltd	Novel composition
PL376577A1 (pl) *	2002-06-17	2006-01-09	Themis Laboratories Private Limited	Wielowarstwowe tabletki zawierające tiazolidinedion i biguanidy oraz metody ich wytwarzania
EP1552832A1 (en) *	2002-07-11	2005-07-13	Takeda Pharmaceutical Company Limited	Process for producing coated preparation
US8637512B2 (en) *	2002-07-29	2014-01-28	Glaxo Group Limited	Formulations and method of treatment
US8084058B2 (en)	2002-09-20	2011-12-27	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en)	2002-09-20	2015-06-23	Actavis, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en)	2002-09-20	2010-08-31	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en)	2002-09-20	2011-06-14	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
CN101623274B (zh) *	2002-09-20	2012-06-27	华生制药公司	含有双胍和噻唑烷二酮衍生物的药物剂型
UA80991C2 (en) *	2002-10-07	2007-11-26		Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
BRPI0407074A (pt)	2003-01-29	2006-01-24	Takeda Pharmaceutical	Método para produção de uma preparação revestida, preparação revestida, e, método para melhorar a dissolução do cloridreto de pioglitazona de uma preparação revestida com cloridreto de pioglitazona
FR2858556B1 (fr) *	2003-08-06	2006-03-10	Galenix Innovations	Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
CA2562391A1 (en) *	2004-04-14	2005-10-27	Takeda Pharmaceutical Company Limited	Solid pharmaceutical preparation
WO2006011397A1 (ja) *	2004-07-27	2006-02-02	Kowa Company., Ltd.	糖尿病の予防または治療のための薬剤
SI1878426T1 (sl) *	2005-04-26	2010-09-30	Dainippon Sumitomo Pharma Co	Granulatni pripravek ki vsebuje bigvanidno spojino
WO2007072992A2 (en)	2005-12-22	2007-06-28	Takeda Pharmaceutical Company Limited	Solid preparation containing an insulin sensitizer
FR2896159B1 (fr)	2006-01-13	2008-09-12	Merck Sante Soc Par Actions Si	Combinaison de derives de triazine et d'agents sensibilisateurs a l'insuline.
JP4893750B2 (ja)	2006-12-26	2012-03-07	富士通株式会社	データ圧縮装置およびデータ復元装置
NZ579008A (en)	2007-02-01	2012-02-24	Takeda Pharmaceutical	Solid preparation comprising alogliptin and pioglitazone
PL2120878T3 (pl)	2007-02-09	2015-01-30	Alphapharm Pty Ltd	Postać dawkowania zawierająca dwa czynne składniki farmaceutyczne o różnych postaciach fizycznych
TR200803177A2 (tr) *	2008-05-06	2009-11-23	Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş.	Antihiperglisemik etkili metformîn - pioglitazon formülasyonu.
US8846315B2 (en)	2008-08-12	2014-09-30	Zinfandel Pharmaceuticals, Inc.	Disease risk factors and methods of use
MX2011001671A (es)	2008-08-12	2011-06-17	Zinfandel Pharmaceuticals Inc	Metodo de identificacion de factores de riesgo de la enfermedad.
FR2951945B1 (fr) *	2009-11-05	2013-08-09	Sanofi Aventis	Composition pharmaceutique
MX345777B (es) *	2009-11-13	2017-02-14	Astrazeneca Ab	Formulaciones de tabletas bicapa.
EP2441442A1 (en)	2010-10-08	2012-04-18	LEK Pharmaceuticals d.d.	A pharmaceutical composition comprising a thiazolidinedione
US11974971B2 (en)	2011-01-07	2024-05-07	Anji Pharmaceuticals Inc.	Compositions and methods for treating metabolic disorders
US9211263B2 (en)	2012-01-06	2015-12-15	Elcelyx Therapeutics, Inc.	Compositions and methods of treating metabolic disorders
US8796338B2 (en)	2011-01-07	2014-08-05	Elcelyx Therapeutics, Inc	Biguanide compositions and methods of treating metabolic disorders
US9572784B2 (en)	2011-01-07	2017-02-21	Elcelyx Therapeutics, Inc.	Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
PT2661266T (pt)	2011-01-07	2020-11-30	Anji Pharma Us Llc	Terapias com base em ligandos do recetor quimiossensorial
US9480663B2 (en)	2011-01-07	2016-11-01	Elcelyx Therapeutics, Inc.	Biguanide compositions and methods of treating metabolic disorders
US11759441B2 (en)	2011-01-07	2023-09-19	Anji Pharmaceuticals Inc.	Biguanide compositions and methods of treating metabolic disorders
UA114704C2 (uk)	2011-01-10	2017-07-25	Зінфандел Фармасьютікалз, Інк.	Способи та лікарські засоби для лікування хвороби альцгеймера
AU2012363873B2 (en)	2012-01-06	2017-11-23	Anji Pharmaceuticals Inc.	Biguanide compositions and methods of treating metabolic disorders
BR112014016810A8 (pt)	2012-01-06	2017-07-04	Elcelyx Therapeutics Inc	composições e métodos para tratamento de distúrbios metabólicos
CN108451923A (zh) *	2018-05-31	2018-08-28	常州兰陵制药有限公司	盐酸二甲双胍速释胶囊及其制备方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS4613596Y1 (no) *	1969-06-02	1971-05-14
DE2347531A1 (de) *	1973-09-21	1975-04-30	Hoechst Ag	Arzneizubereitungen zur oralen diabetes-behandlung
EP0306228B1 (en) *	1987-09-04	1999-11-17	Beecham Group Plc	Substituted thiazolidinedione derivatives
US4999226A (en)	1988-06-01	1991-03-12	Merrell Dow Pharmaceuticals Inc.	Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
JPH0553521A (ja)	1991-08-28	1993-03-05	Mitsubishi Electric Corp	オートトラツキング型ｃｒｔデイスプレイモニタ
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
IT1255522B (it)	1992-09-24	1995-11-09	Ubaldo Conte	Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
US6183778B1 (en)	1993-09-21	2001-02-06	Jagotec Ag	Pharmaceutical tablet capable of liberating one or more drugs at different release rates
TW438587B (en)	1995-06-20	2001-06-07	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes
DE19539361A1 (de)	1995-10-23	1997-04-24	Basf Ag	Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
GB9612496D0 (en)	1996-06-14	1996-08-14	De La Rue Thomas & Co Ltd	Security device
TW522014B (en)	1997-02-07	2003-03-01	Sepracor Inc	Lactose-free, non-hygroscopic and anhydrous pharmaceutical unit dosage form containing descarboethoxyloratadine
US20020004515A1 (en)	1997-06-18	2002-01-10	Smith Stephen Alistair	Treatment of diabetes with thiazolidinedione and metformin
EP1787646A3 (en) *	1997-06-18	2007-10-03	Smithkline Beecham Plc	Novel method of treatment
GB9715295D0 (en) *	1997-07-18	1997-09-24	Smithkline Beecham Plc	Novel method of treatment
AU736951C (en)	1998-03-19	2003-02-20	Bristol-Myers Squibb Company	Biphasic controlled release delivery system for high solubility pharmaceuticals and method
US6099859A (en)	1998-03-20	2000-08-08	Andrx Pharmaceuticals, Inc.	Controlled release oral tablet having a unitary core
US6117451A (en) *	1998-08-25	2000-09-12	Pharmalogix, Inc.	Direct compression metformin hydrochloride tablets
GB9824893D0 (en)	1998-11-12	1999-01-06	Smithkline Beckman Corp	Novel method of treatment
AR023699A1 (es)	1998-11-12	2002-09-04	Smithkline Beecham Corp	Una composicion farmaceutica que comprende un estabilizador de insulina y un procedimiento para preparar una composicion farmaceutica
US20040081697A1 (en)	1998-11-12	2004-04-29	Smithkline Beecham P.L.C.	Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
SK287038B6 (sk)	1998-11-12	2009-10-07	Smithkline Beecham Plc	Farmaceutický prostriedok na postupné uvoľňovanie 5-[4-[2-(N- metyl-N-(2-pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu a metformínu a spôsob jeho výroby
US20040102486A1 (en)	1998-11-12	2004-05-27	Smithkline Beecham Corporation	Novel method of treatment
WO2001035940A2 (en)	1999-11-16	2001-05-25	Smithkline Beecham P.L.C.	Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride
US6451342B2 (en)	2000-05-01	2002-09-17	Aeropharm Technology Incorporated	Core formulation comprised of troglitazone and a biguanide
US6524621B2 (en)	2000-05-01	2003-02-25	Aeropharm Technology Inc.	Core formulation
US6461639B2 (en)	2000-05-01	2002-10-08	Aeropharm Technology, Inc.	Core formulation
US6780432B1 (en)	2000-05-01	2004-08-24	Aeropharm Technology, Inc.	Core formulation
US6296874B1 (en)	2000-05-01	2001-10-02	Aeropharm Technology Incorporated	Core formulation comprising troglitazone and abiguanide
US6403121B1 (en)	2000-05-01	2002-06-11	Aeropharm Technology Incorporated	Core formulation
GB0318824D0 (en)	2003-08-11	2003-09-10	Glaxo Group Ltd	Novel composition

2000
- 2000-11-15 AR ARP000106019A patent/AR030920A1/es active IP Right Grant
- 2000-11-15 MY MYPI20005360A patent/MY125516A/en unknown
- 2000-11-16 CA CA002388846A patent/CA2388846A1/en not_active Abandoned
- 2000-11-16 NZ NZ518946A patent/NZ518946A/en not_active IP Right Cessation
- 2000-11-16 EP EP00976156A patent/EP1231918B1/en not_active Expired - Lifetime
- 2000-11-16 EP EP07120386A patent/EP1913945A3/en not_active Withdrawn
- 2000-11-16 ES ES00976156T patent/ES2240199T3/es not_active Expired - Lifetime
- 2000-11-16 UA UA2002064826A patent/UA73150C2/uk unknown
- 2000-11-16 SI SI200030697T patent/SI1231918T1/xx unknown
- 2000-11-16 WO PCT/GB2000/004368 patent/WO2001035941A2/en active Application Filing
- 2000-11-16 PT PT00976156T patent/PT1231918E/pt unknown
- 2000-11-16 IL IL14961800A patent/IL149618A0/xx unknown
- 2000-11-16 PE PE2000001226A patent/PE20011011A1/es not_active Application Discontinuation
- 2000-11-16 AP APAP/P/2002/002505A patent/AP1389A/en active
- 2000-11-16 AU AU14040/01A patent/AU775654B2/en not_active Expired
- 2000-11-16 JP JP2001537934A patent/JP4865975B2/ja not_active Expired - Lifetime
- 2000-11-16 UY UY26439A patent/UY26439A1/es not_active IP Right Cessation
- 2000-11-16 BR BR0015605-1A patent/BR0015605A/pt not_active Application Discontinuation
- 2000-11-16 EP EP04078538A patent/EP1520581A1/en not_active Withdrawn
- 2000-11-16 PL PL355331A patent/PL200943B1/pl unknown
- 2000-11-16 CZ CZ20021679A patent/CZ302500B6/cs not_active IP Right Cessation
- 2000-11-16 OA OA1200200145A patent/OA12513A/en unknown
- 2000-11-16 EA EA200200571A patent/EA004878B1/ru not_active IP Right Cessation
- 2000-11-16 ME MEP-2008-340A patent/ME00318B/me unknown
- 2000-11-16 SK SK679-2002A patent/SK286985B6/sk not_active IP Right Cessation
- 2000-11-16 DK DK00976156T patent/DK1231918T3/da active
- 2000-11-16 HU HU0204122A patent/HU229960B1/hu unknown
- 2000-11-16 DZ DZ003251A patent/DZ3251A1/fr active
- 2000-11-16 RS YUP-388/02A patent/RS51343B/sr unknown
- 2000-11-16 AT AT00976156T patent/ATE292466T1/de active
- 2000-11-16 DE DE60019329T patent/DE60019329T2/de not_active Expired - Lifetime
- 2000-11-16 CN CNB008178224A patent/CN1222290C/zh not_active Expired - Lifetime
- 2000-11-16 MX MXPA02005005A patent/MXPA02005005A/es active IP Right Grant
- 2000-11-16 KR KR1020027006271A patent/KR100760063B1/ko active IP Right Grant
- 2000-11-20 CO CO00088045A patent/CO5300392A1/es not_active Application Discontinuation
- 2000-12-04 TW TW089125730A patent/TWI240626B/zh not_active IP Right Cessation
2002
- 2002-05-13 IL IL149618A patent/IL149618A/en unknown
- 2002-05-14 HR HR20020416A patent/HRP20020416B1/xx not_active IP Right Cessation
- 2002-05-15 MA MA26640A patent/MA25567A1/fr unknown
- 2002-05-15 NO NO20022334A patent/NO329926B1/no not_active IP Right Cessation
- 2002-05-29 BG BG106747A patent/BG65616B1/bg unknown
2003
- 2003-01-29 HK HK03100745.5A patent/HK1049788B/zh not_active IP Right Cessation
2004
- 2004-11-04 AU AU2004226955A patent/AU2004226955B2/en not_active Expired
2006
- 2006-12-05 AR ARP060105370A patent/AR057970A2/es active IP Right Grant
2007
- 2007-07-18 US US11/779,546 patent/US8236345B2/en not_active Expired - Fee Related
2008
- 2008-03-17 IL IL190220A patent/IL190220A0/en unknown
- 2008-08-18 AU AU2008207375A patent/AU2008207375A1/en not_active Abandoned
2011
- 2011-08-11 JP JP2011175883A patent/JP5282130B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AR030920A1 (es)	2003-09-03
KR100760063B1 (ko)	2007-09-18
UA73150C2 (uk)	2005-06-15
NZ518946A (en)	2003-10-31
CN1414852A (zh)	2003-04-30
AR057970A2 (es)	2007-12-26
EP1231918B1 (en)	2005-04-06
KR20030019300A (ko)	2003-03-06
EP1231918A2 (en)	2002-08-21
DE60019329D1 (de)	2005-05-12
OA12513A (en)	2006-05-29
WO2001035941A2 (en)	2001-05-25
HRP20020416A2 (en)	2004-08-31
BG106747A (en)	2003-01-31
ES2240199T3 (es)	2005-10-16
HK1049788A1 (en)	2003-05-30
ATE292466T1 (de)	2005-04-15
AP2002002505A0 (en)	2002-06-30
PT1231918E (pt)	2005-08-31
AU2004226955A1 (en)	2004-12-02
SI1231918T1 (en)	2005-08-31
JP5282130B2 (ja)	2013-09-04
SK286985B6 (sk)	2009-08-06
PL200943B1 (pl)	2009-02-27
UY26439A1 (es)	2001-07-31
DZ3251A1 (fr)	2001-05-25
AU775654B2 (en)	2004-08-12
DK1231918T3 (da)	2005-08-01
EA200200571A1 (ru)	2002-12-26
ME00318B (me)	2011-05-10
JP2011252007A (ja)	2011-12-15
EP1913945A2 (en)	2008-04-23
EP1520581A1 (en)	2005-04-06
HUP0204122A2 (hu)	2003-03-28
WO2001035941A8 (en)	2002-08-29
MY125516A (en)	2006-08-30
CN1222290C (zh)	2005-10-12
MXPA02005005A (es)	2003-10-14
JP4865975B2 (ja)	2012-02-01
AU1404001A (en)	2001-05-30
EA004878B1 (ru)	2004-08-26
AP1389A (en)	2005-04-14
WO2001035941A3 (en)	2002-05-23
HRP20020416B1 (en)	2011-04-30
CA2388846A1 (en)	2001-05-25
AU2008207375A1 (en)	2008-09-11
IL190220A0 (en)	2008-11-03
HK1049788B (zh)	2005-11-04
YU38802A (sh)	2005-03-15
JP2003514012A (ja)	2003-04-15
MA25567A1 (fr)	2002-10-01
SK6792002A3 (en)	2002-09-10
BG65616B1 (bg)	2009-03-31
HUP0204122A3 (en)	2006-01-30
IL149618A (en)	2008-07-08
PE20011011A1 (es)	2001-10-28
CZ302500B6 (cs)	2011-06-22
AU2004226955B2 (en)	2008-08-28
HU229960B1 (hu)	2015-03-30
CO5300392A1 (es)	2003-07-31
BR0015605A (pt)	2002-07-09
NO20022334D0 (no)	2002-05-15
US20070275054A1 (en)	2007-11-29
EP1913945A3 (en)	2008-04-30
MEP34008A (en)	2011-02-10
TWI240626B (en)	2005-10-01
US8236345B2 (en)	2012-08-07
PL355331A1 (en)	2004-04-19
DE60019329T2 (de)	2006-03-09
IL149618A0 (en)	2002-12-01
RS51343B (sr)	2011-02-28
NO329926B1 (no)	2011-01-24

Publication	Publication Date	Title
NO20022334L (no)	2002-07-09	Ny sammensetning og anvendelse
DK1233964T3 (da)	2005-09-19	Ny anvendelse og hidtil ukendte N-azabicycloamidderivater
NO20032753D0 (no)	2003-06-17	Forbindelse og anvendelse derav
NO20013393L (no)	2001-07-09	Bronnsementeringsfremgangsmater og sammensetninger
NO20006488D0 (no)	2000-12-19	Sammensetning og anvendelse
NO20021116D0 (no)	2002-03-06	Ny sammensetning
DK1112003T3 (da)	2003-08-04	Ny sammensætning og anvendelse
NO20000847L (no)	2000-08-23	Elastiske brønnsementsammensetninger og fremgangsmÕter
NO20000011D0 (no)	2000-01-03	Skumdempersammensetninger og fremgangsmåter
IS6411A (is)	2002-06-06	Kaspasa tálmar og notkun þeirra
NO20021449D0 (no)	2002-03-22	Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
DK1339292T3 (da)	2010-04-12	Sammensætning og fremgangsmåde
DE50112013D1 (de)	2007-03-22	Deodorantien und antiperspirantien
NO20021115D0 (no)	2002-03-06	Ny sammensetning
PT1139761E (pt)	2003-10-31	Composicoes herbicidas e concentrados tensioactivos
DE69916503D1 (de)	2004-05-19	Poliermittelzusammensetzung und anwendungsverfahren
FI20001715A0 (fi)	2000-07-27	Rankoihin liittyvät järjestelyt ja menetelmät
DE69916694D1 (de)	2004-06-03	2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
DE60028486D1 (de)	2006-07-20	Videocoder und -decoder
NO20013085D0 (no)	2001-06-21	Fosfororganiske forbindelser og deres anvendelse
NO20005763D0 (no)	2000-11-14	DHEA-sammensetning og metode
FIU990494U0 (fi)	1999-12-03	Uusi koostumus
NO20005483L (no)	2000-12-08	Ny sammensetning
NO20011313L (no)	2001-05-16	Ny sammensetning
NO20025135L (no)	2002-11-27	Antihypertensive midler og anvendelse

Legal Events

Date	Code	Title	Description
2020-12-07	MK1K	Patent expired